← Leaderboards
Min-Jong Kang
Yale University
$4,511,979
Attributed
$4,860,211
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $762.1K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,860,211 · 5
By mechanism
R01$4,088,340 · 3
R56$771,871 · 2
Top collaborators
- Insoo Kang2 shared
Most similar at Yale University
Same institution · by research overlap
- Maor Sauler$4,743,742
- Fayyaz S. Sutterwala$7,281,640
- Mary E. Choi$7,200,453
- Patty J Lee$9,547,461
- George B Richerson$18,281,692
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsNucleotidesLeucine-Rich RepeatIn VivoLungRestorationMitochondriaMacrophagePlayPathway InteractionsCharacteristicsBindingMutantMediatingChronic Obstructive Airway DiseaseAttenuatedPathogenesisSignal TransductionPulmonary EmphysemaTransgenic OrganismsOverexpressionProductionCellsCell Aging
Grant awards (13)
Investigating the interface of NLRX1 and immune aging$344,715
R01 · FY2025 · AG
Investigating the interface of NLRX1 and immune aging$351,750
R01 · FY2024 · AG
The Reduction of NLRX1 and Its Role in Pulmonary Aging$343,373
R56 · FY2021 · AG · contact PI
The reduction of NLRX1 and its role in pulmonary aging$343,375
R01 · FY2020 · AG · contact PI
Role of NLRX1 in cigarette smoke-induced pulmonary inflammation and remodeling$418,750
R01 · FY2019 · HL · contact PI
The reduction of NLRX1 and its role in pulmonary aging$343,375
R01 · FY2019 · AG · contact PI
Role of NLRX1 in cigarette smoke-induced pulmonary inflammation and remodeling$418,750
R01 · FY2018 · HL · contact PI
The reduction of NLRX1 and its role in pulmonary aging$343,375
R01 · FY2018 · AG · contact PI
Role of NLRX1 in cigarette smoke-induced pulmonary inflammation and remodeling$418,750
R01 · FY2017 · HL · contact PI
The reduction of NLRX1 and its role in pulmonary aging$343,375
R01 · FY2017 · AG · contact PI
Role of NLRX1 in cigarette smoke-induced pulmonary inflammation and remodeling$418,750
R01 · FY2016 · HL · contact PI
The reduction of NLRX1 and its role in pulmonary aging$343,375
R01 · FY2016 · AG · contact PI
NLRX1 and MAVS in cigarette smoke-induced inflammation and alveolar remodeling$428,498
R56 · FY2014 · HL · contact PI